Crowdonomics
WatchlistPortfolio
All companies
MedChain logo

MedChain

Operating

MedChain Inc

Software & AI · Castle Rock, CO

Visit website
Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$467,396
Across 1 round since 2017
Latest share price
$2.00
Reg CF · Common Stock · Dec 2017 offering price

Financials

FY2015–FY2018 · from SEC filings · hover any figure for its source
$0
2015
$0
2016
$0
2017
$0
$508K
2018
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2015 reviewed
FY2016 reviewed
FY2017
FY2018
Income statement
Revenue
$0
$0
$0
$0
Cost of goods sold
$0
$0
$0
$507,902
Net income
$0
$0
$0
$507,902
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$0
$0
$0
$44,934
Accounts receivable
$0
$0
$0
$0
Total assets
$0
$0
$0
$44,934
Short-term debt
$0
$0
$11,491
$166,247
Long-term debt
$0
$0
$14,718
$47,527
Total liabilities
$0
$0
$26,209
$213,774
Other
Headcount
—
2
—
2

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Fundraising history

Reg CF · Common Stock · Dec 2017Closedvia StartEngine
Raised $467.4K / $1.1MInvestors 491

Team

8 people
Joachim SandgaardFounder
Founder, Director & CEO

Joachim Sandgaard is a seasoned IT professional in the healthcare and medical device industry with more than 19 years of experience, including as System Administrator('09-'13) and IT/Project Manager('05-'13 & '15-'17) at Zynex Medical, a Durable Medical Equipment company. He has extensive knowledge of current EMR system integration, document management, and healthcare compliance regulations. Additionally operated Viking Detailing LLC, as sole owner(2014-'15), and acted as Regional Sales Manager for Zynex Medical (2014-'15). Founded MedChain in 2017 and is currently acting as a Director and as the CEO of the company.

Thomas SandgaardFounder
Director & Co-Founder

Thomas Sandgaard is an entrepreneur in the medical device industry. He started his career in Europe with Siemens, Philips Telecom, Dataco, and ITT before founding Zynex Medical, a Durable Medical Equipment company, in 1996. As Chairman, Chief Executive Officer and President he took Zynex Medical public in 2004 (stock symbol: ZYXI) and holds a BS in Electrical Engineering from the University of South Denmark as well as an MBA from Copenhagen Business School. Co-Founded MedChain in 2017 and is currently a Director of the company.

Steve Wishstar
Chief Technical Officer

Sr. Fullstack Developer with 10 years of CTO experience working directly with NASA, Lockheed Martin & Raytheon. Master's Degree in Aeronautics & Astronautics from Stanford University

Alex Bowman
Creative Director

Thoughtful, multidisciplinary designer with a broad range of expertise in website design, branding, and photography.

Clifford Neuman
General Counsel

Principal Clifford L Neuman, P.C.

Gene Libov
Information Security Advisor

Experienced Chief Information Security Officer and former Director of Security and Technology Assurance at Blue Shield of California.

Gregory Sichenzia
SEC Attorney

Founding member, Sichenzia Ross Ference Kesner

Jay Yamamoto
SEC Attorney

Partner, Sichenzia Ross Ference Kesner

Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 1 of 9 annual reports (FY2017–FY2025)

Missing: 2017, 2019, 2020, 2021, 2022, 2023, 2024, 2025

491 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARApr 30, 20190001665160-19-000481
    EDGAR
  • Form C-UMay 1, 20180001665160-18-000391
    EDGAR
  • Form C/AApr 11, 20180001665160-18-000282
    EDGAR
  • Form C/AFeb 28, 20180001665160-18-000130
    EDGAR
  • Form CDec 29, 20170001665160-17-000720
    EDGAR
Source: SEC EDGARCIK 0001726640DEShare price $2.00Last synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.